Skip to main content
Log in

Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients

  • Clinical and Basic Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

One hundred thirteen patients undergoing cardiopulmonary bypass were randomly assigned to receive either bovine or porcine heparin. Heparin was infused at 4.5 mg/kg during bypass and administered at the lesser of 70 units/kg or 5000 units/dose at 12-hour intervals postoperatively. Platelet counts decreased to 45% of preoperative levels during the first 3 days postoperatively (porcine, 44±13%, n =50; bovine, 46±15%), but returned to preoperative levels by the seventh postoperative day. The average blood loss in the porcine heparin group significantly exceeded that of the bovine heparin group (porcine, 1350.7±727.8 ml; bovine, 1059.6±381.0 ml; p<.01). Consequently, the platelet transfusion requirement was greater in the porcine heparin group (porcine, 1.7±3.9 units; bovine, 0.5±1.7 units; p<.05); however, blood and blood component (with the exception of platelets) administration was not significantly different between the two groups. The four patients taking anticoagulants or antiinflammatory agents in the porcine group required a mean of 8.5 units of red blood cells (RBC) plus supplemental platelets. The seven such patients in the bovine group received a mean of 3.0 units of RBC and no platelets. Thus, the use of porcine heparin resulted in a generalized increase in postoperative bleeding with increased management problems in patients undergoing cardiopulmonary bypass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Parker-Williams EJ. Platelets in prosthesis and pumps.Clin Haematol 1972:1:413.

    Google Scholar 

  2. Gollub S, Ulin AW. Heparin induced thrombocytopenia in man.J Lab Clin Med 1962;59:430–434.

    PubMed  Google Scholar 

  3. Jkeub HG, Bell WR. Disseminated intravascular coagulation during heparin therapy.Ann Intern Med 1974;80:477–481.

    PubMed  Google Scholar 

  4. Bell WR, Royall RM. Heparin-associated thrombocytopenia: A comparison of three heparin preparations.N Engl J Med 1980;303:902–907.

    PubMed  Google Scholar 

  5. Eika C. On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.Scand J Hacmatol 1972;9:247.

    Google Scholar 

  6. Thompson C, Forbes CD, Martin E, et al. Potentiation of the platelet aggregation and adhesion by heparin both in vivo and in vitro.Clin Sci 1973;44:21.

    Google Scholar 

  7. McKenna R, Backman F, Whittaker B, et al. The hemostatic mechanism after open heart surgery II. Frequency of abnormal platelet functions during and after extracorporeal circulation.J Thorac Cardiorasc Surg 1975;70:298–308.

    Google Scholar 

  8. O'Brian JR, Etherington M, Jamieson S. Refractory state of platelet aggregation with major operations.Lancet 1971;2: 741–743.

    PubMed  Google Scholar 

  9. Hershgold EJ, Pasquini R, Christiansen D. Effect of heparin-protamine complexes on in vitro platelet aggregation. III Congress of the International Society on Thrombosis and Haemostasis, Washington, DC, 1972;204.

  10. Pike OM, Marquiss JE, Weiner RS, et al. A study of platelet counts during cardiopulmonary bypass.Transfusion 1972; 12:119–121.

    PubMed  Google Scholar 

  11. Schmidt PJ, Peden JC, Brecker G, et al. Thrombocytopenia and bleeding tendency after extracorporeal circulation.N Engl J Med 1961;265:1181–1185.

    PubMed  Google Scholar 

  12. Rent R, Ertel N, Eisenstein R, et al. Complement activation by interaction of polyanions and polycations. 1. Heparin-protamine induced consumption of complement.J Immunol 1976;23:264.

    Google Scholar 

  13. Cimo PL, Moake J, Weinger R, et al. Heparin induced thrombocytopenia. Association with a platelet aggregating factor and arterial thrombosis.Am J Hematol 1979;6:125.

    PubMed  Google Scholar 

  14. Abbott WM, Warnock DF, Austen WG. Relationship of heparin source to the incidence of delayed hemorrhage.J Surg Res 1977;22:593.

    PubMed  Google Scholar 

  15. Cines DB, Kaywin P, Bina M, et al. Heparin associated thrombocytopenia.N Engl J Med 1980;14:788–795.

    Google Scholar 

  16. Huisse M, Guillin M, Bezeaud A, et al. Heparin associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions.Thromb Res 1982;27:485.

    PubMed  Google Scholar 

  17. Ockelford PA, Carter CJ, Cerskus CA, et al. Comparison of the in vivo hemorrhagic effects of a low antithrombin-III affinity heparin fraction.Thromb Res 1982;27:679.

    PubMed  Google Scholar 

  18. Salzman EW, Rosenberg RD, Smith MH, et al. Effect of heparin and heparin fractions on platelet aggregation.J Clin Inrest 1980;65:64–66.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iverson, L.I.G., Duhaylongsod, F.G., Nilas Young, J. et al. Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients. Cardiovasc Drug Ther 4, 269–272 (1990). https://doi.org/10.1007/BF01857644

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857644

Key Words

Navigation